Book a Meeting

Anti-CD20 Antibody, Non-Fucosylated (CAT#: BioBet-008ZP) Datasheet

Target
CD20
Isotype
IgG2a
Description
Anti-CD20 Antibody, Non-Fucosylated (BioBet-008ZP) is a mouse monoclonal IgG2a antibody against CD20. This product is an ADCC enhanced antibody produced by our Afuco™ platform.
Antibody Indication
Chronic lymphocytic leukemia; follicular lymphoma; some types of non-Hodgkin lymphoma (NHL);some non-cancer related illnesses
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced CD20 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
MS4A1
Full Name
membrane spanning 4-domains A1
Background
This gene encodes a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. This gene encodes a B-lymphocyte surface molecule which plays a role in the development and differentiation of B-cells into plasma cells. This family member is localized to 11q12, among a cluster of family members. Alternative splicing of this gene results in two transcript variants which encode the same protein.
Alternative Names
B1; S7; Bp35; CD20; CVID5; MS4A2; LEU-16
Gene ID
931
UniProt ID
P11836
Cellular Localization
Plasma membrane
Involvement in Disease
Diseases associated with MS4A1 include Immunodeficiency, Common Variable, 5 and Common Variable Immunodeficiency.
Related Pathways
Its related pathways are Hematopoietic cell lineage and Hematopoietic Stem Cells and Lineage-specific Markers.
Function
b lymphocyte-specific membrane protein, which is involved in the regulation of cellular calcium influx necessary for the development, differentiation and activation of b lymphocytes (PubMed:3925015, PubMed:7684739, PubMed:12920111). After activation of b-cell receptor/BCR, it acts as a component of stored and operated calcium (SOC) channels to promote calcium influx (PubMed:7684739, PubMed:12920111, PubMed:18474602).
Field of research
Cancer antibody; Developmental Biology antibody; Immune System antibody; B cell Marker antibody; Immature B Cell Marker antibody; Inflammatory Cell Marker antibody; Tumor-infiltrating Lymphocyte Study antibody
Post-translational modifications
Phosphorylated. Might be functionally regulated by protein kinase(s).
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG2a
Antibody Clone
BioBet-008ZP
Host
Mouse
Species Reactivity
Human
Description
Tositumomab is a murine IgG2aλ monoclonal antibody against the CD20 antigen, produced in mammalian cells. Tositumomab is used in combination with the radioisotope iodine 131, a drug combination known as Bexxar. Tositumomab was developed by Corixa and approved in 2003 for a personalized protocol to treat relapsed and refractory non-Hodgkin's lymphoma.
Antibody Indication
Chronic Lymphocytic Leukaemia (CLL)
Chronic Lymphocytic Leukemia (CLL) - Refractory

For treatment of non-Hodgkin's lymphoma (CD20 positive, follicular)
Blood cancers
Chronic Lymphocytic Leukaemia (CLL)
Chronic Lymphocytic Leukemia (CLL) - Refractory

Related Products

Anti-CD20 Antibody, Highly Galactosylated (CAT#: BioBet-GA-001ZP)
Highly Galactosylated Anti-CD20 (Ofatumumab) Antibody (CAT#: BioBet-GA-003ZP)
Non-Fucosylated Anti-Human CD20 (B-Ly1) Therapeutic Antibody (CAT#: BioBet-1667ZP)
Highly Galactosylated Anti-CD20 (Tositumomab) Antibody (CAT#: BioBet-GA-008ZP)
Highly Galactosylated Anti-CD20 (Ibritumomab) Antibody (CAT#: BioBet-GA-350ZP)
Non-fucosylated Anti-Human CD20 (Ibritumomab) Therapeutic Antibody (CAT#: BioBet-029ZP)
Non-Fucosylated Anti-Human CD20 (Ublituximab) Therapeutic Antibody (CAT#: BioBet-1840ZP)
Highly Galactosylated Anti-CD20 (Ocrelizumab) Antibody (CAT#: BioBet-GA-048ZP)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.